YE2-BE4max
(Plasmid
#138156)
-
PurposeC-to-T base editor
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 138156 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBR322/CMV
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namerAPOBEC1(YE2)-nSpCas9-UGI-UGI
-
SpeciesSynthetic; fusion of genes derived from R. norvegicus, S. pyogenes, and Bacillus phage PBS2
-
MutationWithin rAPOBEC1 W90Y + R132E; within Cas9 D10A
- Promoter CMV
-
Tags
/ Fusion Proteins
- NLS (N terminal on insert)
- NLS (C terminal on insert)
Cloning Information
- Cloning method Ligation Independent Cloning
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
YE2-BE4max was a gift from David Liu (Addgene plasmid # 138156 ; http://n2t.net/addgene:138156 ; RRID:Addgene_138156) -
For your References section:
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Doman JL, Raguram A, Newby GA, Liu DR. Nat Biotechnol. 2020 Feb 10. pii: 10.1038/s41587-020-0414-6. doi: 10.1038/s41587-020-0414-6. 10.1038/s41587-020-0414-6 PubMed 32042165